Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Unique Treatment for Autism Based on Hidden Dyslexia/ADHD Cerebellar Mechanisms, reported by Dr. Harold Levinson
  • USA - English


News provided by

Levinson Medical Center for Learning Disabilities

Jan 21, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

9 year old Jordan Johnson, successfully treated by Dr. Levinson
9 year old Jordan Johnson, successfully treated by Dr. Levinson

For the first time ever, he actually reminded me that he needed to have his homework done. This meant that he developed new organizational and planning skills as well as greater memory and interest.

Post this

New York, NY (PRWEB) January 21, 2014 -- Considering that Autism has evaded all determined scientific causal and medical therapeutic efforts to date, a unique medical treatment offered to minimize symptoms in this often debilitating disorder deserves significant attention. Because an inner-ear and related cerebellar fine-tuning impairment was verified to characterize Autism by many researchers, Dr. Levinson chose to treat this signal-scrambling defect utilizing diverse combinations of inner-ear-improving medications and nutrients. He believed the autistic language and communication disorder was akin to an aphasic-like primary cerebral processing defect. And by enhancing signal clarity, Levinson believed residual brain processing capacity would secondarily improve as would the interrelated and collateral symptoms resulting directly from the cerebellar impairment.

"In freeing autistics from as many treatable secondary emotional and neurophysiological functional blockers as possible,” said Levinson, "I believed autistics would have the best possible chance of maximizing their innate compensatory endowments while stimulating new ones via enhanced neuroplastic changes. There was absolutely nothing to lose by trying, and so much to gain."

By choosing to experimentally treat the relatively "minor" cerebellar and related symptomatic fallout now rather than waiting for a primary autistic therapeutic breakthrough nowhere in scientific sight, Levinson also discovered new help and relief for a group of other "major" brain processing disorders previously left in "suspended therapeutic animation," such as the intellectually impaired, brain injured, Down's syndrome patients, etc. As Levinson put it, "Since the front door to treating Autism was hidden, I decided to use the back door. It was far more productive than just waiting around. Although not a cure by any means, any rapid medically-triggered improvement was deemed infinitely better than none. And better functioning autistics would more significantly respond to all other helpful therapeutic modalities."

Dr. Levinson had previously demonstrated that dyslexia and related ADHD and phobic/anxiety disorders, as well as developmental coordination, speech, and central auditory processing impairments, all resulted when initially normal brain structures and mechanisms failed to process the scrambled signals received and transmitted. These "dizzy" signals were found by Levinson due to a fine-tuning defect of primary cerebellar origin which responded very favorably and rapidly to inner-ear improving medications. Levinson's theory also explained the overlapping or comorbidity of all the above disorders with each other. Additionally, it explained the coexistence of the above "minor" disorders in "major" brain processing impairments having cerebellar involvement, like Autism, in which speech, language, social and communication, as well as sensory-motor and repetitive or OCD-like issues, existed.

According to Levinson, "It seemed natural to treat the cerebellar impairment wherever I found it, irrespective of the diversely named disorders it occurred in. This simple insight made all the difference for many with Autism and over a score of other variously named impairments." By medically improving the signal-scrambling within the brain, those with major cerebral and other brain processing disorders like Autism had only one serious problem to deal with instead of two or more overwhelming impairments. Following successful treatment, their residual brain processing capacity often increased when dealing with normal rather than confusing "dizzy" signals. In addition, all the primary cerebellar determined symptoms and mechanisms characterizing the above and many other relatively "minor" disorders (LD, ADHD, dysgraphia, dyscalculia, dyspraxia, phobias, etc.) often significantly and rapidly improved as well. And by enhancing concentration, sensory-motor functioning, speech, memory, mood, frustration tolerance, etc. while decreasing distractibility, hyperactivity, anxiety and impulsivity, it became possible to maximize overall functional capabilities in autistic individuals.

No doubt, the following improvements in a recently treated child previously diagnosed with Autism and ADHD, as well as overlapping cerebellar impairments, will be highly instructive.

Jordan Johnson is 9 years old. Following 6 months of treatment with Dr. Levinson for a coexisting cerebellar-vestibular (CV) dysfunction, Jordan's language and communication skills improved sufficiently so that he only manifested mild autistic traits, not autism. Thus his latest diagnosis was: ADHD-ATs (Autistic Traits)/Dyslexia.

According to his mother, Lois Johnson: “Jordan was diagnosed with autism at age two and a half. Before seeing Dr Levinson when 9-years-old, Jordan was in his own world. He was very hard to motivate. He did things in his own time and was unaware and unaffected by social pressures. It was very hard to follow his train of thought. His statements seemed random, as if he were telling you something from the middle of the story rather than the beginning. It seemed as though he was just a little bit off… as if a switch needed to be flipped.

“But once we started treatment, changes began. The switch was definitely turned on. I started noticing Jordan saying things… as if he was more in the moment. For the first time ever, he actually reminded me that he needed to have his homework done. This meant that he developed new organizational and planning skills as well as greater memory and interest.

“His teacher told me that he seemed more assertive, volunteered to write on the chalkboard, and followed along more during class. He also could relay a story to me of what happened at school, something that he could never do in the past. He bargains more, argues more, and even tried to pull the wool over my eyes. All of those things are typical for his age but something I never saw before.

“As we reached our 6th month on Dr. Levinson's program, Jordan's speech and communication improvements continued to surprise me more and more. He asked me what the word 'pregnant' meant that he had heard on TV. He also started listening to my conversations and then asking me pertinent questions about what was said.

“I now understand a lot more about what he is saying and I can follow his train of thought. As a result of all his improvements, I am very pleased and very hopeful.”

An Explanatory Summary Comment: By medically improving both the inner-ear/cerebellar determined auditory processing as well as the motor, sequencing, concentration and memory mechanisms responsible for both receptive and expressive speech functioning while decreasing anxiety, hyperactivity and distractibility, etc., the primarily impaired language and communication difficulties are often minimized in autism and especially so in its milder subtype called ATs (autistic traits), as exemplified by Jordan. As initially reported by Levinson, new Harvard research has shown that ADHD is related to the cerebellum and that 20% of children with ADHD have mild autistic traits. Neuroimaging brain studies have also verified cerebellar involvement in dyslexia, anxiety and depressive disorders as well as autism, intellectual impairments, etc.

About Harold Levinson, M.D.

Formerly Clinical Associate Professor of Psychiatry at New York University Medical Center, Dr. Harold Levinson is currently Director of the Levinson Medical Center for Learning Disabilities in Long Island, New York. He is a well-known neuropsychiatrist, clinical researcher and author. His "highly original" initially controversial research into the cerebellar-vestibular (inner-ear) origins and treatment of dyslexia and related learning, attention-deficit/hyperactivity and anxiety or phobic disorders has evolved over the past four decades. Initially supported by Nobel Laureate Sir John Eccles and other outstanding cerebellar neurophysiologists and inner-ear scientists, Levinson's research has more recently been independently validated worldwide by highly sophisticated neuroimaging brain studies. For more information, call 1(800) 334-7323 or visit http://www.dyslexiaonline.com.

Dr.Harold Levinson, Levinson Medical Center for Learning Disabilities, http://www.dyslexiaonline.com, +1 516-482-2888, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.